SMi’s 4th Annual Ophthalmic Drugs conference returning to London, takes place at the Copthorne Tara Hotel in Kensington, London on the 16th – 17th November 2020.
The global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market.
With that in mind, SMi is proud to present the 4th Annual Ophthalmic Drugs Conference taking place on the 16th-17th of November 2020, in London.
As Europe’s leading Ophthalmic Drugs conference, we will explore new discoveries in the treatment of ocular rare disease, innovations in gene therapy, the challenges in drug delivery through a complex barrier, patient comfort, and regulatory compliance which make up such core components within the Ophthalmic Drug sphere.
This three-day agenda offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more.